"Centro Malattie dell’Apparato Digerente della Fondazione Policlinico Universitario Agostino Gemelli di Roma. Direttore Professor Antonio Gasbarrini."

During the past decade, Fondazione Policlinico Universitario Agostino Gemelli IRCCS - CEMAD conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fondazione Policlinico Universitario Agostino Gemelli IRCCS - CEMAD" #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Fondazione Policlinico Universitario Agostino Gemelli IRCCS - CEMAD" are "Ulcerative Colitis" (3 trials). Many other conditions were trialed in "Fondazione Policlinico Universitario Agostino Gemelli IRCCS - CEMAD" in a lesser frequency.

Most popular intervention types in "Fondazione Policlinico Universitario Agostino Gemelli IRCCS - CEMAD" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Etrasimod" (3 trials) and "Placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "Fondazione Policlinico Universitario Agostino Gemelli IRCCS - CEMAD" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Fondazione Policlinico Universitario Agostino Gemelli IRCCS - CEMAD". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Fondazione Policlinico Universitario Agostino Gemelli IRCCS - CEMAD, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Fondazione Policlinico Universitario Agostino Gemelli IRCCS - CEMAD, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".